Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
ozanimod sphingosine 1-phosphate receptor 1 small molecule NA drugbank , DGIDB Syndrome[MeSHID:D013577]
Relapse[MeSHID:D012008]
Disease[MeSHID:D004194]
Neoplasm Metastasis[MeSHID:D009362]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Ulcerative Colitis[MeSHID:D003093]
Multiple Sclerosis[MeSHID:D009103]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Crohn Disease[MeSHID:D003424]		 3.64 approved,investigational agonist
ozanimod sphingosine-1-phosphate receptor 1 NA Successful target TTD , DGIDB Syndrome[MeSHID:D013577]
Relapse[MeSHID:D012008]
Disease[MeSHID:D004194]
Neoplasm Metastasis[MeSHID:D009362]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Ulcerative Colitis[MeSHID:D003093]
Multiple Sclerosis[MeSHID:D009103]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Crohn Disease[MeSHID:D003424]		 3.64 approved unknown
ozanimod sphingosine-1-phosphate receptor 1 NA Successful target TTD , DGIDB Syndrome[MeSHID:D013577]
Relapse[MeSHID:D012008]
Disease[MeSHID:D004194]
Neoplasm Metastasis[MeSHID:D009362]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Ulcerative Colitis[MeSHID:D003093]
Multiple Sclerosis[MeSHID:D009103]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Crohn Disease[MeSHID:D003424]		 3.64 approved agonist
ozanimod sphingosine 1-phosphate receptor 5 small molecule NA drugbank , DGIDB Syndrome[MeSHID:D013577]
Relapse[MeSHID:D012008]
Disease[MeSHID:D004194]
Neoplasm Metastasis[MeSHID:D009362]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Ulcerative Colitis[MeSHID:D003093]
Multiple Sclerosis[MeSHID:D009103]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Crohn Disease[MeSHID:D003424]		 6.37 approved,investigational agonist
click here to return to the previous page